Form 4: CoreWeave CDO Sells Shares via 10b5-1 Plan
Insider Transaction Report
CoreWeave's Chief Development Officer, Brannin McBee, executed pre-planned sales of Class A Common Stock on December 8, 2025, totaling 166,670 shares at prices around $83.80.
Summary
- Brannin McBee, Chief Development Officer of CoreWeave, Inc., reported multiple transactions on December 8, 2025.
- Transactions included the conversion of 166,170 shares of Class B Common Stock into Class A Common Stock.
- A total of 166,670 shares of Class A Common Stock were subsequently sold, including the converted shares and an additional 500 shares from the Canis Major SM Trust.
- All sales were conducted under a Rule 10b5-1 trading plan adopted on September 2, 2025.
- Sales prices ranged from $83.7711 to $83.8034 per share.
- Beneficial ownership is held directly and indirectly through various trusts and family members, as detailed in the filing.
Sentiment
Score: 5
Explanation: The transactions represent pre-scheduled sales by an insider under a Rule 10b5-1 plan, which typically indicates a planned liquidity event rather than a reaction to new information about the company's prospects.
Negatives
- Chief Development Officer Brannin McBee sold a total of 166,670 shares of Class A Common Stock.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Sales were made from the Brannin J. McBee 2022 Irrevocable Trust, Canis Major 2024 Irrevocable Trust LLC, Canis Major 2025 Family Trust LLC, Canis Minor 2025 Family Trust LLC, Canis Major 2025 GRAT, Canis Minor 2025 GRAT, and Canis Major SM Trust, all linked to the reporting person or their family.
Stakeholder Impact
- Shareholders: Insider selling, even if pre-planned, can sometimes be viewed with caution, though 10b5-1 plans mitigate the negative signal.
Key Dates
| Date | Description |
|---|---|
| 09/02/2025 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 12/08/2025 | Date of reported transactions, including conversions and sales of Class A Common Stock. |
| 12/10/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe reported transactions are routine insider sales executed under a pre-established 10b5-1 trading plan. While insider selling can sometimes be a negative signal, the pre-planned nature suggests personal financial planning rather than a reaction to new, adverse company information. Therefore, these transactions alone do not warrant a change in investment recommendation, maintaining a 'hold' stance based on existing fundamentals.
Keywords
CoreWeave, CRWV, Form 4, insider trading, stock sale, 10b5-1 plan, Brannin McBee, Chief Development Officer, equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.